BG Medicine (OTCMKTS:BGMD) Stock Crosses Above 200 Day Moving Average – Time to Sell?

BG Medicine, Inc. (OTCMKTS:BGMDGet Free Report)’s share price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.00. BG Medicine shares last traded at $0.00, with a volume of 11,820 shares changing hands.

BG Medicine Trading Up 9,900.0 %

BG Medicine Company Profile

(Get Free Report)

BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.

Recommended Stories

Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with MarketBeat.com's FREE daily email newsletter.